123 related articles for article (PubMed ID: 21163685)
1. Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis.
Chang KP; Kao HK; Yen TC; Chang YL; Liang Y; Liu SC; Lee LY; Chang YL; Kang CJ; Chen IH; Liao CT; Yu JS
Oral Oncol; 2011 Feb; 47(2):108-13. PubMed ID: 21163685
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
3. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS
Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993
[TBL] [Abstract][Full Text] [Related]
4. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology.
Chang KP; Yu JS; Chien KY; Lee CW; Liang Y; Liao CT; Yen TC; Lee LY; Huang LL; Liu SC; Chang YS; Chi LM
J Proteome Res; 2011 Nov; 10(11):4935-47. PubMed ID: 21859152
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
[TBL] [Abstract][Full Text] [Related]
7. Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma.
Abiko Y; Nishimura M; Kusano K; Nakashima K; Okumura K; Arakawa T; Takuma T; Mizoguchi I; Kaku T
Arch Oral Biol; 2003 Feb; 48(2):171-5. PubMed ID: 12642237
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.
Shang ZJ; Liu K; Shao Z
Oral Oncol; 2009 Jun; 45(6):480-5. PubMed ID: 18752985
[TBL] [Abstract][Full Text] [Related]
12. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
15. IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma.
Lai KC; Chang KW; Liu CJ; Kao SY; Lee TC
Mol Cancer Res; 2008 Sep; 6(9):1431-9. PubMed ID: 18819931
[TBL] [Abstract][Full Text] [Related]
16. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
17. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
[TBL] [Abstract][Full Text] [Related]
18. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
19. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
Dos Reis PP; Bharadwaj RR; Machado J; Macmillan C; Pintilie M; Sukhai MA; Perez-Ordonez B; Gullane P; Irish J; Kamel-Reid S
Cancer; 2008 Dec; 113(11):3169-80. PubMed ID: 18991282
[TBL] [Abstract][Full Text] [Related]
20. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]